Table of Contents Global Age Related Macular Degeneration Drug Sales Market Report 2018 1 Age Related Macular Degeneration Drug Market Overview 1.1 Product Overview and Scope of Age Related Macular Degeneration Drug 1.2 Classification of Age Related Macular Degeneration Drug by Product Category 1.2.1 Global Age Related Macular Degeneration Drug Market Size (Sales) Comparison by Type (2013-2025) 1.2.2 Global Age Related Macular Degeneration Drug Market Size (Sales) Market Share by Type (Product Category) in 2017 1.2.3 Lucentis 1.2.4 Eylea 1.2.5 Avastin 1.2.6 Others 1.3 Global Age Related Macular Degeneration Drug Market by Application/End Users 1.3.1 Global Age Related Macular Degeneration Drug Sales (Volume) and Market Share Comparison by Application (2013-2025) 1.3.2 Clinic 1.3.3 Hospital 1.3.4 Others 1.4 Global Age Related Macular Degeneration Drug Market by Region 1.4.1 Global Age Related Macular Degeneration Drug Market Size (Value) Comparison by Region (2013-2025) 1.4.2 United States Age Related Macular Degeneration Drug Status and Prospect (2013-2025) 1.4.3 Europe Age Related Macular Degeneration Drug Status and Prospect (2013-2025) 1.4.4 China Age Related Macular Degeneration Drug Status and Prospect (2013-2025) 1.4.5 Japan Age Related Macular Degeneration Drug Status and Prospect (2013-2025) 1.4.6 Southeast Asia Age Related Macular Degeneration Drug Status and Prospect (2013-2025) 1.4.7 India Age Related Macular Degeneration Drug Status and Prospect (2013-2025) 1.5 Global Market Size (Value and Volume) of Age Related Macular Degeneration Drug (2013-2025) 1.5.1 Global Age Related Macular Degeneration Drug Sales and Growth Rate (2013-2025) 1.5.2 Global Age Related Macular Degeneration Drug Revenue and Growth Rate (2013-2025) 2 Global Age Related Macular Degeneration Drug Competition by Players/Suppliers, Type and Application 2.1 Global Age Related Macular Degeneration Drug Market Competition by Players/Suppliers 2.1.1 Global Age Related Macular Degeneration Drug Sales and Market Share of Key Players/Suppliers (2013-2018) 2.1.2 Global Age Related Macular Degeneration Drug Revenue and Share by Players/Suppliers (2013-2018) 2.2 Global Age Related Macular Degeneration Drug (Volume and Value) by Type 2.2.1 Global Age Related Macular Degeneration Drug Sales and Market Share by Type (2013-2018) 2.2.2 Global Age Related Macular Degeneration Drug Revenue and Market Share by Type (2013-2018) 2.3 Global Age Related Macular Degeneration Drug (Volume and Value) by Region 2.3.1 Global Age Related Macular Degeneration Drug Sales and Market Share by Region (2013-2018) 2.3.2 Global Age Related Macular Degeneration Drug Revenue and Market Share by Region (2013-2018) 2.4 Global Age Related Macular Degeneration Drug (Volume) by Application 3 United States Age Related Macular Degeneration Drug (Volume, Value and Sales Price) 3.1 United States Age Related Macular Degeneration Drug Sales and Value (2013-2018) 3.1.1 United States Age Related Macular Degeneration Drug Sales and Growth Rate (2013-2018) 3.1.2 United States Age Related Macular Degeneration Drug Revenue and Growth Rate (2013-2018) 3.1.3 United States Age Related Macular Degeneration Drug Sales Price Trend (2013-2018) 3.2 United States Age Related Macular Degeneration Drug Sales Volume and Market Share by Players (2013-2018) 3.3 United States Age Related Macular Degeneration Drug Sales Volume and Market Share by Type (2013-2018) 3.4 United States Age Related Macular Degeneration Drug Sales Volume and Market Share by Application (2013-2018) 4 Europe Age Related Macular Degeneration Drug (Volume, Value and Sales Price) 4.1 Europe Age Related Macular Degeneration Drug Sales and Value (2013-2018) 4.1.1 Europe Age Related Macular Degeneration Drug Sales and Growth Rate (2013-2018) 4.1.2 Europe Age Related Macular Degeneration Drug Revenue and Growth Rate (2013-2018) 4.1.3 Europe Age Related Macular Degeneration Drug Sales Price Trend (2013-2018) 4.2 Europe Age Related Macular Degeneration Drug Sales Volume and Market Share by Players (2013-2018) 4.3 Europe Age Related Macular Degeneration Drug Sales Volume and Market Share by Type (2013-2018) 4.4 Europe Age Related Macular Degeneration Drug Sales Volume and Market Share by Application (2013-2018) 5 China Age Related Macular Degeneration Drug (Volume, Value and Sales Price) 5.1 China Age Related Macular Degeneration Drug Sales and Value (2013-2018) 5.1.1 China Age Related Macular Degeneration Drug Sales and Growth Rate (2013-2018) 5.1.2 China Age Related Macular Degeneration Drug Revenue and Growth Rate (2013-2018) 5.1.3 China Age Related Macular Degeneration Drug Sales Price Trend (2013-2018) 5.2 China Age Related Macular Degeneration Drug Sales Volume and Market Share by Players (2013-2018) 5.3 China Age Related Macular Degeneration Drug Sales Volume and Market Share by Type (2013-2018) 5.4 China Age Related Macular Degeneration Drug Sales Volume and Market Share by Application (2013-2018) 6 Japan Age Related Macular Degeneration Drug (Volume, Value and Sales Price) 6.1 Japan Age Related Macular Degeneration Drug Sales and Value (2013-2018) 6.1.1 Japan Age Related Macular Degeneration Drug Sales and Growth Rate (2013-2018) 6.1.2 Japan Age Related Macular Degeneration Drug Revenue and Growth Rate (2013-2018) 6.1.3 Japan Age Related Macular Degeneration Drug Sales Price Trend (2013-2018) 6.2 Japan Age Related Macular Degeneration Drug Sales Volume and Market Share by Players (2013-2018) 6.3 Japan Age Related Macular Degeneration Drug Sales Volume and Market Share by Type (2013-2018) 6.4 Japan Age Related Macular Degeneration Drug Sales Volume and Market Share by Application (2013-2018) 7 Southeast Asia Age Related Macular Degeneration Drug (Volume, Value and Sales Price) 7.1 Southeast Asia Age Related Macular Degeneration Drug Sales and Value (2013-2018) 7.1.1 Southeast Asia Age Related Macular Degeneration Drug Sales and Growth Rate (2013-2018) 7.1.2 Southeast Asia Age Related Macular Degeneration Drug Revenue and Growth Rate (2013-2018) 7.1.3 Southeast Asia Age Related Macular Degeneration Drug Sales Price Trend (2013-2018) 7.2 Southeast Asia Age Related Macular Degeneration Drug Sales Volume and Market Share by Players (2013-2018) 7.3 Southeast Asia Age Related Macular Degeneration Drug Sales Volume and Market Share by Type (2013-2018) 7.4 Southeast Asia Age Related Macular Degeneration Drug Sales Volume and Market Share by Application (2013-2018) 8 India Age Related Macular Degeneration Drug (Volume, Value and Sales Price) 8.1 India Age Related Macular Degeneration Drug Sales and Value (2013-2018) 8.1.1 India Age Related Macular Degeneration Drug Sales and Growth Rate (2013-2018) 8.1.2 India Age Related Macular Degeneration Drug Revenue and Growth Rate (2013-2018) 8.1.3 India Age Related Macular Degeneration Drug Sales Price Trend (2013-2018) 8.2 India Age Related Macular Degeneration Drug Sales Volume and Market Share by Players (2013-2018) 8.3 India Age Related Macular Degeneration Drug Sales Volume and Market Share by Type (2013-2018) 8.4 India Age Related Macular Degeneration Drug Sales Volume and Market Share by Application (2013-2018) 9 Global Age Related Macular Degeneration Drug Players/Suppliers Profiles and Sales Data 9.1 Applied Genetic Technologies Corp 9.1.1 Company Basic Information, Manufacturing Base and Competitors 9.1.2 Age Related Macular Degeneration Drug Product Category, Application and Specification 9.1.2.1 Product A 9.1.2.2 Product B 9.1.3 Applied Genetic Technologies Corp Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2013-2018) 9.1.4 Main Business/Business Overview 9.2 Astellas Pharma Inc 9.2.1 Company Basic Information, Manufacturing Base and Competitors 9.2.2 Age Related Macular Degeneration Drug Product Category, Application and Specification 9.2.2.1 Product A 9.2.2.2 Product B 9.2.3 Astellas Pharma Inc Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2013-2018) 9.2.4 Main Business/Business Overview 9.3 Benitec Biopharma Ltd 9.3.1 Company Basic Information, Manufacturing Base and Competitors 9.3.2 Age Related Macular Degeneration Drug Product Category, Application and Specification 9.3.2.1 Product A 9.3.2.2 Product B 9.3.3 Benitec Biopharma Ltd Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2013-2018) 9.3.4 Main Business/Business Overview 9.4 Biokine Therapeutics Ltd 9.4.1 Company Basic Information, Manufacturing Base and Competitors 9.4.2 Age Related Macular Degeneration Drug Product Category, Application and Specification 9.4.2.1 Product A 9.4.2.2 Product B 9.4.3 Biokine Therapeutics Ltd Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2013-2018) 9.4.4 Main Business/Business Overview 9.5 Crinetics Pharmaceuticals Inc 9.5.1 Company Basic Information, Manufacturing Base and Competitors 9.5.2 Age Related Macular Degeneration Drug Product Category, Application and Specification 9.5.2.1 Product A 9.5.2.2 Product B 9.5.3 Crinetics Pharmaceuticals Inc Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2013-2018) 9.5.4 Main Business/Business Overview 9.6 Critical Pharmaceuticals Ltd 9.6.1 Company Basic Information, Manufacturing Base and Competitors 9.6.2 Age Related Macular Degeneration Drug Product Category, Application and Specification 9.6.2.1 Product A 9.6.2.2 Product B 9.6.3 Critical Pharmaceuticals Ltd Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2013-2018) 9.6.4 Main Business/Business Overview 9.7 Daiichi Sankyo Company Ltd 9.7.1 Company Basic Information, Manufacturing Base and Competitors 9.7.2 Age Related Macular Degeneration Drug Product Category, Application and Specification 9.7.2.1 Product A 9.7.2.2 Product B 9.7.3 Daiichi Sankyo Company Ltd Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2013-2018) 9.7.4 Main Business/Business Overview 9.8 Diffusion Pharmaceuticals Inc 9.8.1 Company Basic Information, Manufacturing Base and Competitors 9.8.2 Age Related Macular Degeneration Drug Product Category, Application and Specification 9.8.2.1 Product A 9.8.2.2 Product B 9.8.3 Diffusion Pharmaceuticals Inc Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2013-2018) 9.8.4 Main Business/Business Overview 9.9 Dong-A Socio Holdings Co Ltd 9.9.1 Company Basic Information, Manufacturing Base and Competitors 9.9.2 Age Related Macular Degeneration Drug Product Category, Application and Specification 9.9.2.1 Product A 9.9.2.2 Product B 9.9.3 Dong-A Socio Holdings Co Ltd Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2013-2018) 9.9.4 Main Business/Business Overview 9.10 Eleven Biotherapeutics Inc 9.10.1 Company Basic Information, Manufacturing Base and Competitors 9.10.2 Age Related Macular Degeneration Drug Product Category, Application and Specification 9.10.2.1 Product A 9.10.2.2 Product B 9.10.3 Eleven Biotherapeutics Inc Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2013-2018) 9.10.4 Main Business/Business Overview 9.11 Elsalys Biotech SAS 9.12 Lupin Ltd 9.13 M's Science Corp 9.14 Mabion SA 9.15 MacuCLEAR Inc 10 Age Related Macular Degeneration Drug Maufacturing Cost Analysis 10.1 Age Related Macular Degeneration Drug Key Raw Materials Analysis 10.1.1 Key Raw Materials 10.1.2 Price Trend of Key Raw Materials 10.1.3 Key Suppliers of Raw Materials 10.1.4 Market Concentration Rate of Raw Materials 10.2 Proportion of Manufacturing Cost Structure 10.2.1 Raw Materials 10.2.2 Labor Cost 10.2.3 Manufacturing Process Analysis of Age Related Macular Degeneration Drug 10.3 Manufacturing Process Analysis of Age Related Macular Degeneration Drug 11 Industrial Chain, Sourcing Strategy and Downstream Buyers 11.1 Age Related Macular Degeneration Drug Industrial Chain Analysis 11.2 Upstream Raw Materials Sourcing 11.3 Raw Materials Sources of Age Related Macular Degeneration Drug Major Manufacturers in 2017 11.4 Downstream Buyers 12 Marketing Strategy Analysis, Distributors/Traders 12.1 Marketing Channel 12.1.1 Direct Marketing 12.1.2 Indirect Marketing 12.1.3 Marketing Channel Development Trend 12.2 Market Positioning 12.2.1 Pricing Strategy 12.2.2 Brand Strategy 12.2.3 Target Client 12.3 Distributors/Traders List 13 Market Effect Factors Analysis 13.1 Technology Progress/Risk 13.1.1 Substitutes Threat 13.1.2 Technology Progress in Related Industry 13.2 Consumer Needs/Customer Preference Change 13.3 Economic/Political Environmental Change 14 Global Age Related Macular Degeneration Drug Market Forecast (2018-2025) 14.1 Global Age Related Macular Degeneration Drug Sales Volume, Revenue and Price Forecast (2018-2025) 14.1.1 Global Age Related Macular Degeneration Drug Sales Volume and Growth Rate Forecast (2018-2025) 14.1.2 Global Age Related Macular Degeneration Drug Revenue and Growth Rate Forecast (2018-2025) 14.1.3 Global Age Related Macular Degeneration Drug Price and Trend Forecast (2018-2025) 14.2 Global Age Related Macular Degeneration Drug Sales Volume, Revenue and Growth Rate Forecast by Region (2018-2025) 14.2.1 Global Age Related Macular Degeneration Drug Sales Volume and Growth Rate Forecast by Regions (2018-2025) 14.2.2 Global Age Related Macular Degeneration Drug Revenue and Growth Rate Forecast by Regions (2018-2025) 14.2.3 United States Age Related Macular Degeneration Drug Sales Volume, Revenue and Growth Rate Forecast (2018-2025) 14.2.4 Europe Age Related Macular Degeneration Drug Sales Volume, Revenue and Growth Rate Forecast (2018-2025) 14.2.5 China Age Related Macular Degeneration Drug Sales Volume, Revenue and Growth Rate Forecast (2018-2025) 14.2.6 Japan Age Related Macular Degeneration Drug Sales Volume, Revenue and Growth Rate Forecast (2018-2025) 14.2.7 Southeast Asia Age Related Macular Degeneration Drug Sales Volume, Revenue and Growth Rate Forecast (2018-2025) 14.2.8 India Age Related Macular Degeneration Drug Sales Volume, Revenue and Growth Rate Forecast (2018-2025) 14.3 Global Age Related Macular Degeneration Drug Sales Volume, Revenue and Price Forecast by Type (2018-2025) 14.3.1 Global Age Related Macular Degeneration Drug Sales Forecast by Type (2018-2025) 14.3.2 Global Age Related Macular Degeneration Drug Revenue Forecast by Type (2018-2025) 14.3.3 Global Age Related Macular Degeneration Drug Price Forecast by Type (2018-2025) 14.4 Global Age Related Macular Degeneration Drug Sales Volume Forecast by Application (2018-2025) 15 Research Findings and Conclusion 16 Appendix 16.1 Methodology/Research Approach 16.1.1 Research Programs/Design 16.1.2 Market Size Estimation 16.1.3 Market Breakdown and Data Triangulation 16.2 Data Source 16.2.1 Secondary Sources 16.2.2 Primary Sources 16.3 Disclaimer

List of Tables and Figures Figure Product Picture of Age Related Macular Degeneration Drug Figure Global Age Related Macular Degeneration Drug Sales Volume Comparison (K Pcs) by Type (2013-2025) Figure Global Age Related Macular Degeneration Drug Sales Volume Market Share by Type (Product Category) in 2017 Figure Lucentis Product Picture Figure Eylea Product Picture Figure Avastin Product Picture Figure Others Product Picture Figure Global Age Related Macular Degeneration Drug Sales Comparison (K Pcs) by Application (2013-2025) Figure Global Sales Market Share of Age Related Macular Degeneration Drug by Application in 2017 Figure Clinic Examples Table Key Downstream Customer in Clinic Figure Hospital Examples Table Key Downstream Customer in Hospital Figure Others Examples Table Key Downstream Customer in Others Figure Global Age Related Macular Degeneration Drug Market Size (Million USD) by Regions (2013-2025) Figure United States Age Related Macular Degeneration Drug Revenue (Million USD) and Growth Rate (2013-2025) Figure Europe Age Related Macular Degeneration Drug Revenue (Million USD) and Growth Rate (2013-2025) Figure China Age Related Macular Degeneration Drug Revenue (Million USD) and Growth Rate (2013-2025) Figure Japan Age Related Macular Degeneration Drug Revenue (Million USD) and Growth Rate (2013-2025) Figure Southeast Asia Age Related Macular Degeneration Drug Revenue (Million USD) and Growth Rate (2013-2025) Figure India Age Related Macular Degeneration Drug Revenue (Million USD) and Growth Rate (2013-2025) Figure Global Age Related Macular Degeneration Drug Sales Volume (K Pcs) and Growth Rate (2013-2025) Figure Global Age Related Macular Degeneration Drug Revenue (Million USD) and Growth Rate (2013-2025) Figure Global Market Major Players Age Related Macular Degeneration Drug Sales Volume (K Pcs) (2013-2018) Table Global Age Related Macular Degeneration Drug Sales (K Pcs) of Key Players/Suppliers (2013-2018) Table Global Age Related Macular Degeneration Drug Sales Share by Players/Suppliers (2013-2018) Figure 2017 Age Related Macular Degeneration Drug Sales Share by Players/Suppliers Figure 2017 Age Related Macular Degeneration Drug Sales Share by Players/Suppliers Figure Global Age Related Macular Degeneration Drug Revenue (Million USD) by Players/Suppliers (2013-2018) Table Global Age Related Macular Degeneration Drug Revenue (Million USD) by Players/Suppliers (2013-2018) Table Global Age Related Macular Degeneration Drug Revenue Share by Players/Suppliers (2013-2018) Table 2017 Global Age Related Macular Degeneration Drug Revenue Share by Players Table 2017 Global Age Related Macular Degeneration Drug Revenue Share by Players Table Global Age Related Macular Degeneration Drug Sales (K Pcs) and Market Share by Type (2013-2018) Table Global Age Related Macular Degeneration Drug Sales Share (K Pcs) by Type (2013-2018) Figure Sales Market Share of Age Related Macular Degeneration Drug by Type (2013-2018) Figure Global Age Related Macular Degeneration Drug Sales Growth Rate by Type (2013-2018) Table Global Age Related Macular Degeneration Drug Revenue (Million USD) and Market Share by Type (2013-2018) Table Global Age Related Macular Degeneration Drug Revenue Share by Type (2013-2018) Figure Revenue Market Share of Age Related Macular Degeneration Drug by Type (2013-2018) Figure Global Age Related Macular Degeneration Drug Revenue Growth Rate by Type (2013-2018) Table Global Age Related Macular Degeneration Drug Sales Volume (K Pcs) and Market Share by Region (2013-2018) Table Global Age Related Macular Degeneration Drug Sales Share by Region (2013-2018) Figure Sales Market Share of Age Related Macular Degeneration Drug by Region (2013-2018) Figure Global Age Related Macular Degeneration Drug Sales Growth Rate by Region in 2017 Table Global Age Related Macular Degeneration Drug Revenue (Million USD) and Market Share by Region (2013-2018) Table Global Age Related Macular Degeneration Drug Revenue Share (%) by Region (2013-2018) Figure Revenue Market Share of Age Related Macular Degeneration Drug by Region (2013-2018) Figure Global Age Related Macular Degeneration Drug Revenue Growth Rate by Region in 2017 Table Global Age Related Macular Degeneration Drug Revenue (Million USD) and Market Share by Region (2013-2018) Table Global Age Related Macular Degeneration Drug Revenue Share (%) by Region (2013-2018) Figure Revenue Market Share of Age Related Macular Degeneration Drug by Region (2013-2018) Figure Global Age Related Macular Degeneration Drug Revenue Market Share by Region in 2017 Table Global Age Related Macular Degeneration Drug Sales Volume (K Pcs) and Market Share by Application (2013-2018) Table Global Age Related Macular Degeneration Drug Sales Share (%) by Application (2013-2018) Figure Sales Market Share of Age Related Macular Degeneration Drug by Application (2013-2018) Figure Global Age Related Macular Degeneration Drug Sales Market Share by Application (2013-2018) Figure United States Age Related Macular Degeneration Drug Sales (K Pcs) and Growth Rate (2013-2018) Figure United States Age Related Macular Degeneration Drug Revenue (Million USD) and Growth Rate (2013-2018) Figure United States Age Related Macular Degeneration Drug Sales Price (USD/Pcs) Trend (2013-2018) Table United States Age Related Macular Degeneration Drug Sales Volume (K Pcs) by Players (2013-2018) Table United States Age Related Macular Degeneration Drug Sales Volume Market Share by Players (2013-2018) Figure United States Age Related Macular Degeneration Drug Sales Volume Market Share by Players in 2017 Table United States Age Related Macular Degeneration Drug Sales Volume (K Pcs) by Type (2013-2018) Table United States Age Related Macular Degeneration Drug Sales Volume Market Share by Type (2013-2018) Figure United States Age Related Macular Degeneration Drug Sales Volume Market Share by Type in 2017 Table United States Age Related Macular Degeneration Drug Sales Volume (K Pcs) by Application (2013-2018) Table United States Age Related Macular Degeneration Drug Sales Volume Market Share by Application (2013-2018) Figure United States Age Related Macular Degeneration Drug Sales Volume Market Share by Application in 2017 Figure Europe Age Related Macular Degeneration Drug Sales (K Pcs) and Growth Rate (2013-2018) Figure Europe Age Related Macular Degeneration Drug Revenue (Million USD) and Growth Rate (2013-2018) Figure Europe Age Related Macular Degeneration Drug Sales Price (USD/Pcs) Trend (2013-2018) Table Europe Age Related Macular Degeneration Drug Sales Volume (K Pcs) by Players (2013-2018) Table Europe Age Related Macular Degeneration Drug Sales Volume Market Share by Players (2013-2018) Figure Europe Age Related Macular Degeneration Drug Sales Volume Market Share by Players in 2017 Table Europe Age Related Macular Degeneration Drug Sales Volume (K Pcs) by Type (2013-2018) Table Europe Age Related Macular Degeneration Drug Sales Volume Market Share by Type (2013-2018) Figure Europe Age Related Macular Degeneration Drug Sales Volume Market Share by Type in 2017 Table Europe Age Related Macular Degeneration Drug Sales Volume (K Pcs) by Application (2013-2018) Table Europe Age Related Macular Degeneration Drug Sales Volume Market Share by Application (2013-2018) Figure Europe Age Related Macular Degeneration Drug Sales Volume Market Share by Application in 2017 Figure China Age Related Macular Degeneration Drug Sales (K Pcs) and Growth Rate (2013-2018) Figure China Age Related Macular Degeneration Drug Revenue (Million USD) and Growth Rate (2013-2018) Figure China Age Related Macular Degeneration Drug Sales Price (USD/Pcs) Trend (2013-2018) Table China Age Related Macular Degeneration Drug Sales Volume (K Pcs) by Players (2013-2018) Table China Age Related Macular Degeneration Drug Sales Volume Market Share by Players (2013-2018) Figure China Age Related Macular Degeneration Drug Sales Volume Market Share by Players in 2017 Table China Age Related Macular Degeneration Drug Sales Volume (K Pcs) by Type (2013-2018) Table China Age Related Macular Degeneration Drug Sales Volume Market Share by Type (2013-2018) Figure China Age Related Macular Degeneration Drug Sales Volume Market Share by Type in 2017 Table China Age Related Macular Degeneration Drug Sales Volume (K Pcs) by Application (2013-2018) Table China Age Related Macular Degeneration Drug Sales Volume Market Share by Application (2013-2018) Figure China Age Related Macular Degeneration Drug Sales Volume Market Share by Application in 2017 Figure Japan Age Related Macular Degeneration Drug Sales (K Pcs) and Growth Rate (2013-2018) Figure Japan Age Related Macular Degeneration Drug Revenue (Million USD) and Growth Rate (2013-2018) Figure Japan Age Related Macular Degeneration Drug Sales Price (USD/Pcs) Trend (2013-2018) Table Japan Age Related Macular Degeneration Drug Sales Volume (K Pcs) by Players (2013-2018) Table Japan Age Related Macular Degeneration Drug Sales Volume Market Share by Players (2013-2018) Figure Japan Age Related Macular Degeneration Drug Sales Volume Market Share by Players in 2017 Table Japan Age Related Macular Degeneration Drug Sales Volume (K Pcs) by Type (2013-2018) Table Japan Age Related Macular Degeneration Drug Sales Volume Market Share by Type (2013-2018) Figure Japan Age Related Macular Degeneration Drug Sales Volume Market Share by Type in 2017 Table Japan Age Related Macular Degeneration Drug Sales Volume (K Pcs) by Application (2013-2018) Table Japan Age Related Macular Degeneration Drug Sales Volume Market Share by Application (2013-2018) Figure Japan Age Related Macular Degeneration Drug Sales Volume Market Share by Application in 2017 Figure Southeast Asia Age Related Macular Degeneration Drug Sales (K Pcs) and Growth Rate (2013-2018) Figure Southeast Asia Age Related Macular Degeneration Drug Revenue (Million USD) and Growth Rate (2013-2018) Figure Southeast Asia Age Related Macular Degeneration Drug Sales Price (USD/Pcs) Trend (2013-2018) Table Southeast Asia Age Related Macular Degeneration Drug Sales Volume (K Pcs) by Players (2013-2018) Table Southeast Asia Age Related Macular Degeneration Drug Sales Volume Market Share by Players (2013-2018) Figure Southeast Asia Age Related Macular Degeneration Drug Sales Volume Market Share by Players in 2017 Table Southeast Asia Age Related Macular Degeneration Drug Sales Volume (K Pcs) by Type (2013-2018) Table Southeast Asia Age Related Macular Degeneration Drug Sales Volume Market Share by Type (2013-2018) Figure Southeast Asia Age Related Macular Degeneration Drug Sales Volume Market Share by Type in 2017 Table Southeast Asia Age Related Macular Degeneration Drug Sales Volume (K Pcs) by Application (2013-2018) Table Southeast Asia Age Related Macular Degeneration Drug Sales Volume Market Share by Application (2013-2018) Figure Southeast Asia Age Related Macular Degeneration Drug Sales Volume Market Share by Application in 2017 Figure India Age Related Macular Degeneration Drug Sales (K Pcs) and Growth Rate (2013-2018) Figure India Age Related Macular Degeneration Drug Revenue (Million USD) and Growth Rate (2013-2018) Figure India Age Related Macular Degeneration Drug Sales Price (USD/Pcs) Trend (2013-2018) Table India Age Related Macular Degeneration Drug Sales Volume (K Pcs) by Players (2013-2018) Table India Age Related Macular Degeneration Drug Sales Volume Market Share by Players (2013-2018) Figure India Age Related Macular Degeneration Drug Sales Volume Market Share by Players in 2017 Table India Age Related Macular Degeneration Drug Sales Volume (K Pcs) by Type (2013-2018) Table India Age Related Macular Degeneration Drug Sales Volume Market Share by Type (2013-2018) Figure India Age Related Macular Degeneration Drug Sales Volume Market Share by Type in 2017 Table India Age Related Macular Degeneration Drug Sales Volume (K Pcs) by Application (2013-2018) Table India Age Related Macular Degeneration Drug Sales Volume Market Share by Application (2013-2018) Figure India Age Related Macular Degeneration Drug Sales Volume Market Share by Application in 2017 Table Applied Genetic Technologies Corp Basic Information List Table Applied Genetic Technologies Corp Age Related Macular Degeneration Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018) Figure Applied Genetic Technologies Corp Age Related Macular Degeneration Drug Sales Growth Rate (2013-2018) Figure Applied Genetic Technologies Corp Age Related Macular Degeneration Drug Sales Global Market Share (2013-2018) Figure Applied Genetic Technologies Corp Age Related Macular Degeneration Drug Revenue Global Market Share (2013-2018) Table Astellas Pharma Inc Basic Information List Table Astellas Pharma Inc Age Related Macular Degeneration Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018) Figure Astellas Pharma Inc Age Related Macular Degeneration Drug Sales Growth Rate (2013-2018) Figure Astellas Pharma Inc Age Related Macular Degeneration Drug Sales Global Market Share (2013-2018) Figure Astellas Pharma Inc Age Related Macular Degeneration Drug Revenue Global Market Share (2013-2018) Table Benitec Biopharma Ltd Basic Information List Table Benitec Biopharma Ltd Age Related Macular Degeneration Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018) Figure Benitec Biopharma Ltd Age Related Macular Degeneration Drug Sales Growth Rate (2013-2018) Figure Benitec Biopharma Ltd Age Related Macular Degeneration Drug Sales Global Market Share (2013-2018 Figure Benitec Biopharma Ltd Age Related Macular Degeneration Drug Revenue Global Market Share (2013-2018) Table Biokine Therapeutics Ltd Basic Information List Table Biokine Therapeutics Ltd Age Related Macular Degeneration Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018) Figure Biokine Therapeutics Ltd Age Related Macular Degeneration Drug Sales Growth Rate (2013-2018) Figure Biokine Therapeutics Ltd Age Related Macular Degeneration Drug Sales Global Market Share (2013-2018) Figure Biokine Therapeutics Ltd Age Related Macular Degeneration Drug Revenue Global Market Share (2013-2018) Table Crinetics Pharmaceuticals Inc Basic Information List Table Crinetics Pharmaceuticals Inc Age Related Macular Degeneration Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018) Figure Crinetics Pharmaceuticals Inc Age Related Macular Degeneration Drug Sales Growth Rate (2013-2018) Figure Crinetics Pharmaceuticals Inc Age Related Macular Degeneration Drug Sales Global Market Share (2013-2018) Figure Crinetics Pharmaceuticals Inc Age Related Macular Degeneration Drug Revenue Global Market Share (2013-2018) Table Critical Pharmaceuticals Ltd Basic Information List Table Critical Pharmaceuticals Ltd Age Related Macular Degeneration Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018) Figure Critical Pharmaceuticals Ltd Age Related Macular Degeneration Drug Sales Growth Rate (2013-2018) Figure Critical Pharmaceuticals Ltd Age Related Macular Degeneration Drug Sales Global Market Share (2013-2018 Figure Critical Pharmaceuticals Ltd Age Related Macular Degeneration Drug Revenue Global Market Share (2013-2018) Table Daiichi Sankyo Company Ltd Basic Information List Table Daiichi Sankyo Company Ltd Age Related Macular Degeneration Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018) Figure Daiichi Sankyo Company Ltd Age Related Macular Degeneration Drug Sales Growth Rate (2013-2018) Figure Daiichi Sankyo Company Ltd Age Related Macular Degeneration Drug Sales Global Market Share (2013-2018) Figure Daiichi Sankyo Company Ltd Age Related Macular Degeneration Drug Revenue Global Market Share (2013-2018) Table Diffusion Pharmaceuticals Inc Basic Information List Table Diffusion Pharmaceuticals Inc Age Related Macular Degeneration Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018) Figure Diffusion Pharmaceuticals Inc Age Related Macular Degeneration Drug Sales Growth Rate (2013-2018) Figure Diffusion Pharmaceuticals Inc Age Related Macular Degeneration Drug Sales Global Market Share (2013-2018 Figure Diffusion Pharmaceuticals Inc Age Related Macular Degeneration Drug Revenue Global Market Share (2013-2018) Table Dong-A Socio Holdings Co Ltd Basic Information List Table Dong-A Socio Holdings Co Ltd Age Related Macular Degeneration Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018) Figure Dong-A Socio Holdings Co Ltd Age Related Macular Degeneration Drug Sales Growth Rate (2013-2018) Figure Dong-A Socio Holdings Co Ltd Age Related Macular Degeneration Drug Sales Global Market Share (2013-2018) Figure Dong-A Socio Holdings Co Ltd Age Related Macular Degeneration Drug Revenue Global Market Share (2013-2018) Table Eleven Biotherapeutics Inc Basic Information List Table Eleven Biotherapeutics Inc Age Related Macular Degeneration Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018) Figure Eleven Biotherapeutics Inc Age Related Macular Degeneration Drug Sales Growth Rate (2013-2018) Figure Eleven Biotherapeutics Inc Age Related Macular Degeneration Drug Sales Global Market Share (2013-2018) Figure Eleven Biotherapeutics Inc Age Related Macular Degeneration Drug Revenue Global Market Share (2013-2018) Table Elsalys Biotech SAS Basic Information List Table Lupin Ltd Basic Information List Table M's Science Corp Basic Information List Table Mabion SA Basic Information List Table MacuCLEAR Inc Basic Information List Table Production Base and Market Concentration Rate of Raw Material Figure Price Trend of Key Raw Materials Table Key Suppliers of Raw Materials Figure Manufacturing Cost Structure of Age Related Macular Degeneration Drug Figure Manufacturing Process Analysis of Age Related Macular Degeneration Drug Figure Age Related Macular Degeneration Drug Industrial Chain Analysis Table Raw Materials Sources of Age Related Macular Degeneration Drug Major Players in 2017 Table Major Buyers of Age Related Macular Degeneration Drug Table Distributors/Traders List Figure Global Age Related Macular Degeneration Drug Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025) Figure Global Age Related Macular Degeneration Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025) Figure Global Age Related Macular Degeneration Drug Price (USD/Pcs) and Trend Forecast (2018-2025) Table Global Age Related Macular Degeneration Drug Sales Volume (K Pcs) Forecast by Regions (2018-2025) Figure Global Age Related Macular Degeneration Drug Sales Volume Market Share Forecast by Regions (2018-2025) Figure Global Age Related Macular Degeneration Drug Sales Volume Market Share Forecast by Regions in 2025 Table Global Age Related Macular Degeneration Drug Revenue (Million USD) Forecast by Regions (2018-2025) Figure Global Age Related Macular Degeneration Drug Revenue Market Share Forecast by Regions (2018-2025) Figure Global Age Related Macular Degeneration Drug Revenue Market Share Forecast by Regions in 2025 Figure United States Age Related Macular Degeneration Drug Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025) Figure United States Age Related Macular Degeneration Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025) Figure Europe Age Related Macular Degeneration Drug Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025) Figure Europe Age Related Macular Degeneration Drug Revenue and Growth Rate Forecast (2018-2025) Figure China Age Related Macular Degeneration Drug Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025) Figure China Age Related Macular Degeneration Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025) Figure Japan Age Related Macular Degeneration Drug Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025) Figure Japan Age Related Macular Degeneration Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025) Figure Southeast Asia Age Related Macular Degeneration Drug Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025) Figure Southeast Asia Age Related Macular Degeneration Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025) Figure India Age Related Macular Degeneration Drug Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025) Figure India Age Related Macular Degeneration Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025) Table Global Age Related Macular Degeneration Drug Sales (K Pcs) Forecast by Type (2018-2025) Figure Global Age Related Macular Degeneration Drug Sales Volume Market Share Forecast by Type (2018-2025) Table Global Age Related Macular Degeneration Drug Revenue (Million USD) Forecast by Type (2018-2025) Figure Global Age Related Macular Degeneration Drug Revenue Market Share Forecast by Type (2018-2025) Table Global Age Related Macular Degeneration Drug Price (USD/Pcs) Forecast by Type (2018-2025) Table Global Age Related Macular Degeneration Drug Sales (K Pcs) Forecast by Application (2018-2025) Figure Global Age Related Macular Degeneration Drug Sales Market Share Forecast by Application (2018-2025) Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources